Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation
Authors:
Open Access
- 21 February 2007
- journal article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 62 (3) , 430-435
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hyperproliferation of homocysteinetreated colon cancer cells is reversed by folate and 5-methyltetrahydrofolateEuropean Journal of Nutrition, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acidClinical Transplantation, 2000
- A Positive Family History of Premature Coronary Artery Disease Is Associated With Impaired Endothelium-Dependent Coronary Blood Flow RegulationCirculation, 1999
- Homocysteine in cerebral macroangiography and microangiopathyThe Lancet, 1999
- Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipientsKidney International, 1999
- TEN YEARS OF LIVER TRANSPLANTATIONTransplantation, 1997
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolismBiochemical Journal, 1994